Navigation Links
Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement
Date:11/4/2009

WASHINGTON, Nov. 4 /PRNewswire/ -- Sanford Wittels & Heisler, LLP, along with co-counsel Grant Morris, announced today that AtriCure, Inc., a medical device company specializing in cardiac surgical ablation systems, has reached a tentative settlement agreement with the Department of Justice (DOJ) in a qui tam case filed in 2007 for $3.8 million plus interest over a five-year period.

Sanford Wittels & Heisler and Grant Morris represent the relator in the case against AtriCure, which was filed in the United States District Court for the Southern District of Texas. The complaint charges that AtriCure violated the Federal False Claims Act by using illegal kickbacks and an off-label marketing campaign to induce physicians and hospitals to perform AtriCure's costly inpatient cardiac surgical ablation procedures over standard, and more effective, outpatient catheter ablation procedures. As a result, the Medicare program has faced substantial increased costs from AtriCure's unnecessary and expensive procedures.

"AtriCure has done the right thing by settling this case before an onslaught of negative publicity surrounding the DOJ investigation," said David Sanford, co-lead counsel in the matter against AtriCure.

Specifically, the complaint alleges that AtriCure enticed hospitals to purchase its products by promoting the spread between Medicare reimbursement for AtriCure's surgical ablation procedure and the relatively low cost to the hospital itself. AtriCure further provided physicians and hospitals with kickbacks, including free equipment; price discounts; free advertising, marketing, and referral services; and extensive training for surgeons performing AtriCure procedures.

"This settlement allows us to focus on the remaining three companies under investigation: St. Jude Medical, Boston Scientific, and Medtronic," said Grant Morris, co-lead counsel in the AtriCure qui tam case.

The tentative agreement between AtriCure and the DOJ is subject to the completion and approval of a written settlement agreement.

Sanford Wittels & Heisler is a renowned class action and qui tam law firm with offices in Washington, D.C., New York, and San Francisco that specializes in qui tam, employment discrimination, wage and hour, consumer and complex corporate class action litigation and has represented thousands of individuals in major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters. Individuals with these claims are encouraged to contact Sanford Wittels & Heisler at (202) 742-7777.

SOURCE Sanford Wittels & Heisler, LLP


'/>"/>
SOURCE Sanford Wittels & Heisler, LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
3. ACRO Comments on NEJM Article on Globalization of Clinical Research
4. Arpida Comments on FDAs Anti-infective Drugs Advisory Committee Outcome
5. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
6. Arpida Provides Further Comments on the Pivotal Phase III Trials
7. EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
8. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
9. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
10. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
11. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 ... the  "Global Anesthesia Disposables Market 2016-2020"  report ... ) ,The global anesthesia disposables market ... of 4.03% during the period 2016-2020.  ... threat to patients, safety. Organizations like the ...
(Date:4/27/2016)... SAN FRANCISCO , April 27, 2016 /PRNewswire/ ...  is expected to reach USD 2.06 billion by ... View Research, Inc. Increasing consumer awareness towards a ... over the next seven years.      ... Improper diet intake coupled with rising health treatment ...
(Date:4/26/2016)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... Bank 41 st Annual Health Care Conference on Wednesday, ... are invited to listen to the live discussion via the ... at http://edge.media-server.com/m/p/mr4uxgas . A recorded replay of the discussion ... event and accessible at the links above until August 1, ...
Breaking Medicine Technology:
(Date:4/29/2016)... Toronto, ON (PRWEB) , ... April 29, 2016 ... ... GlutenFreeCoupons.ca and the Canadian Celiac Association (CCA), is pleased to announce the launch ... about gluten-free products, nutritional articles, recipes, and more. The purpose of the ...
(Date:4/29/2016)... ... ... For those who skip meals occasionally (which is pretty much everyone), two ... new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of Tried ... Bonny and Lawrence noted that because proper nutrition, including water, provides energy during the ...
(Date:4/29/2016)... ... 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) -- Dr. ... Potter -- are proud of the recent release of their 2014 in vitro fertilization ... published the latest verified data for 375 U.S. member clinics. *Preliminary data shows ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the April ... the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott Conference ...
(Date:4/29/2016)... ... April 29, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at ... of adding BC and AD, saying it is time to set the record straight. ... Yisrayl says this simply cannot possibly be true and offers explanation. , “To start ...
Breaking Medicine News(10 mins):